Known targets — ChEMBL curated mechanism
ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG
The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | TLR8 | Q9NR97 | 2/20 | 0.42 |
| ▸ | FDPS | P14324 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.39 |
| ▸ | LPO | P22079 | 1/20 | 0.39 |
| ▸ | FNTA | P49354 | 1/20 | 0.38 |
| ▸ | FNTB | P49356 | 1/20 | 0.38 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.36 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | APLNR | P35414 | 1/20 | 0.35 |
| ▸ | DRD4 | P21917 | 1/20 | 0.35 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL40842 | 0.98 | KMT2A (0.46) | KMT2AALDH1A1POLBTLR8FDPS | |
| Hydrochloric Acid SCHEMBL28021855 | 0.96 | KMT2A (0.44) | KMT2AALDH1A1POLBTLR8FDPS | |
| Methane SCHEMBL28225457 | 0.96 | KMT2A (0.44) | KMT2AALDH1A1POLBTLR8FDPS | |
| Fluoride SCHEMBL15156374 | 0.96 | KMT2A (0.44) | KMT2AALDH1A1POLBTLR8FDPS | |
| Bromide SCHEMBL15532009 | 0.96 | KMT2A (0.44) | KMT2AALDH1A1POLBTLR8FDPS | |
| Hydrochloric Acid SCHEMBL28330230 | 0.96 | KMT2A (0.44) | KMT2AALDH1A1POLBTLR8FDPS | |
| Hydrochloric Acid SCHEMBL204294 | 0.96 | TLR8 (0.44) | KMT2AALDH1A1POLBTLR8FDPS | |
| Water SCHEMBL1176982 | 0.96 | KMT2A (0.44) | KMT2AALDH1A1POLBTLR8FDPS | |
| Bromide SCHEMBL204550 | 0.96 | KMT2A (0.44) | KMT2AALDH1A1POLBTLR8FDPS | |
| Bromide SCHEMBL28281143 | 0.94 | KMT2A (0.43) | KMT2AALDH1A1POLBTLR8FDPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 185 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140034869-A1 | Gel Electrolytes For Dye Sensitized Solar Cells | MERCK PATENT GMBH (DE) | 2014-02-06 | — | — | US | claimed |
| US-8581096-B2 | Gel electrolytes for dye sensitized solar cells | MERCK PATENT GMBH (DE) | 2013-11-12 | — | — | US | claimed |
| US-8236974-B2 | Process for preparing glycidyl esters | BASF SE (DE) | 2012-08-07 | — | — | US | claimed |
| US-20090272934-A1 | GEL ELECTROLYTES FOR DYE SENSITIZED SOLAR CELLS | MERCK KGAA (DE) | 2009-11-05 | — | — | US | claimed |
| JP-2005516365-A | — | — | 2005-06-02 | — | — | JP | claimed |
| US-6900382-B2 | Gel electrolytes for dye sensitized solar cells | KONARKA TECHNOLOGIES, INC. (US) | 2005-05-31 | — | — | US | claimed |
| US-20050039790-A1 | Gel electrolytes for dye sensitized solar cells | KONARKA TECHNOLOGIES, INC. (US) | 2005-02-24 | — | — | US | claimed |
| EP-1470563-A2 | PHOTOVOLTAIC CELL COMPONENTS AND MATERIALS | Konarka Technologies, Inc. (US) | 2004-10-27 | — | — | EP | claimed |
| US-20040025933-A1 | Gel electrolytes for dye sensitized solar cells | KONARKA TECHNOLOGIES, INC. (US) | 2004-02-12 | — | — | US | claimed |
| WO-2003065394-A2 | PHOTOVOLTAIC CELL COMPONENTS AND MATERIALS | KONARKA TECHNOLOGIES, INC. (US) | 2003-08-07 | — | — | WO | claimed |
| US-12540199-B2 | Molding material production method and molding material | SEIKO EPSON CORPORATION (JP) | 2026-02-03 | — | — | US | disclosed |
| US-20240317896-A1 | Molding Material Production Method And Molding Material | SEIKO EPSON CORPORATION (JP) | 2024-09-26 | — | — | US | disclosed |
| CN-118684785-A | Method for producing molding material and molding material | 精工爱普生株式会社 | 2024-09-24 | — | — | CN | disclosed |
| US-20230322787-A1 | PROCESS FOR PREPARING ENANTIOMERICALLY ENRICHED JAK INHIBITORS | SUN PHARMACEUTICAL INDUSTRIES, INC. | 2023-10-12 | — | — | US | disclosed |
| EP-4196481-A1 | PROCESS FOR PREPARING ENANTIOMERICALLY ENRICHED JAK INHIBITORS | Concert Pharmaceuticals Inc. (US) | 2023-06-21 | — | — | EP | disclosed |
| US-20030188776-A1 | Photovoltaic powered multimedia greeting cards and smart cards | KONARKA TECHNOLOGIES, INC. | 2003-10-09 | — | — | US | disclosed |
| WO-2003065393-A2 | DISPLAYS WITH INTEGRATED PHOTOVOLTAIC CELLS | KONARKA TECHNOLOGIES, INC. (US) | 2003-08-07 | — | — | WO | disclosed |
| WO-2003065471-A2 | PHOTOVOLTAIC FIBERS | KONARKA TECHNOLOGIES, INC. (US) | 2003-08-07 | — | — | WO | disclosed |
| WO-2003065394-A2 | PHOTOVOLTAIC CELL COMPONENTS AND MATERIALS | KONARKA TECHNOLOGIES, INC. (US) | 2003-08-07 | — | — | WO | disclosed |
| WO-2003065472-A2 | STRUCTURES AND MATERIALS FOR DYE SENSITIZED SOLAR CELLS | KONARKA TECHNOLOGIES, INC. (US) | 2003-08-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12540199-B2 | Molding material production method and molding material | ACP1, RPL28, PLIN3 | KMT2A 996/4885ALDH1A1 2881/4885POLB 2598/4885 |
| US-20230322787-A1 | PROCESS FOR PREPARING ENANTIOMERICALLY ENRICHED JAK INHIBITORS | JAK1, JAK3, JAK2 | KMT2A 1188/4885ALDH1A1 2276/4885POLB 1850/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.